Puzzle: Estimation of half life [Surveys]

posted by ElMaestro  – Denmark, 2013-02-12 20:42 (4869 d 00:39 ago) – Posting: # 10006
Views: 8,184

Hi Helmut,

this happens occasionally with inhalation products and leaves everybody puzzled. If several subjects have such a profile one initial idea is to audit.
If nothing is found, and if SOPs are silent in relation to this situation, then I would say you can calculate AUCt but not kel or AUCinf for such subjects.
Hence I believe the subjects are not lost to evaluation of the primary endpoints Cmax and AUCt. You will of course get questions about the typical max. 20% extrapolation requirement which is impossible to answer in a meaningful manner. If you do business with some authority that requires AUCinf as primary then you have "an issue" and I have no solution which is universally useful.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
122 visitors (0 registered, 122 guests [including 29 identified bots]).
Forum time: 22:21 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5